DataLase and Colorcon Inc. Sign Licensing Agreement to Develop DataLase PHARMAMARK
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
Jean Claude Deneuville, executive vice president, corporate development, at Colorcon Inc. commented, “We see this as a huge step forward for the industry, which will give peace of mind not only to patients, but to pharmacists and medical staff alike. I’m pleased that Colorcon’s and DataLase’s combined experience will be able to solve a problem and satisfy the demand for this technology in the pharmaceutical and nutritional industries.”
0 Comments
View Comments
- Companies:
- Colorcon Inc., No-Tox Products Div.
Related Content
Comments